The critical role of hyperinsulinemia, independent of hyperglycemia, in the pathogenesis of atherosclerosis has not been fully determined. We investigated the association between secretion patterns of insulin after oral glucose load and the severity of coronary artery disease (CAD) in patients with normal glucose tolerance (NGT). 
vascular disease in non-diabetic patients because several results in the major prospective human studies are inconsistent [7] [8] [9] [10] . Several studies using coronary angiogram have shown an association between hyperinsulinemia and the severity of coronary artery disease [11] [12] [13] [14] ; however, almost all the studies included patients with IGT or DM. Therefore, the critical role of hyperinsulinemia, independent of hyperglycemia, in the pathogenesis of atherosclerosis has not been fully determined. Furthermore, it has not been fully demonstrated what type of insulin secretion has the most atherogenic response to glucose load.
To clarify the role of hyperinsulinemia and insulin resistance at the pre-diabetic stage in the pathogenesis of atherosclerosis, we investigated the association between the secretion patterns of insulin after an oral glucose load and the severity of coronary artery disease (CAD) in patients with NGT.
Introduction
Macrovascular disease develops in parallel with the development of type 2 diabetes mellitus (DM) 1, 2) ; however, it is sometimes present before the clinical onset of DM. Numerous studies suggest that an increase in postprandial plasma glucose levels in non-diabetic patients is a strong predictor of cardiovascular events [3] [4] [5] [6] . Hyperinsulinemia is also one of the major candidates that contribute to the development of atherosclerosis in patients with normal glucose tolerance (NGT) as well as in those with impaired glucose tolerance (IGT); however, it is unclear whether fasting and/or postprandial hyperinsulinemia are major risk factors of cardio-
Subjects and Methods

Study Patients
Patients who had undergone coronary angiography to evaluate CAD for various reasons, including typical effort angina, resting angina and abnormal results on electrocardiogram, ultrasound cardiogram, exercise stress electrocardiogram or myocardial perfusion imaging, in our institution from 1997 to 2003, were recruited in this study. We excluded patients with a previous diagnosis of type 1 or 2 diabetes, fasting plasma glucose 7.0 mmol/L, glycosylated hemoglobin (HbA1c) 6.5%, or patients who refused to participate in this study. Patients with ongoing congestive heart failure, liver dysfunction and/or renal dysfunction were also excluded. As a result, 243 patients underwent coronary angiography and a standard 75-g oral glucose tolerance test (OGTT) during the same period. Of the 243 patients, subjects with NGT, IGT, and DM were 116 (48%), 93 (38%), and 34 (14%), respectively. NGT, IGT and DM were defined by 1998 World Health Organization criteria 15) . We finally analyzed 116 subjects with NGT and they comprised 48 patients with typical effort angina (41%), 17 patients with acute myocardial infarction (15%), 8 patients with unstable angina (7%), 17 patients with silent ischemia detected by exercise stress electrocardiogram and/ or myocardial perfusion imaging (15%), 13 patients with old myocardial infarction detected by electrocardiogram and/or ultrasound cardiogram (11%), 9 patients with atypical chest pain (8%) and 4 patients with peripheral vascular disease (3%). All subjects gave informed consent and the study was approved by the ethics committee.
Blood Sampling and Biochemical Analysis
A 75-g OGTT was performed in a fasting state and blood samples for glucose and insulin were drawn just before glucose administration, and 30, 60 and 120 min later. In patients with acute myocardial infarction and unstable angina, a 75-g OGTT was performed just before discharge from our hospital to minimize any possible confounding effects of acute coronary syndrome on glucose and insulin metabolism. The minimal and average periods of time between acute coronary events and 75-g OGTT were 8 days and 16 9 days. Plasma glucose concentrations were determined by the glucose oxidase method (Kainos, Tokyo, Japan), and serum insulin levels were measured by a double antibody technique (Dainabot, Tokyo Japan). Serum levels of total cholesterol, triglycerides and HDL cholesterol were measured by standard enzymatic methods (Kainos, Tokyo, Japan), and LDL cholesterol values were calculated by the Friedewald formula 16) . Apolipoprotein B (apoB) was determined by turbidimetric immunoassay (Daiichi Pure Chemical, Tokyo, Japan). HbA1c was measured by high-performance liquid chromatography with a normal range of 4.3-5.8% (TOHSOH, Tokyo, Japan).
The area under the curve (AUC) for insulin and glucose was calculated using the trapezoidal rule. The homeostasis model assessment for insulin resistance (HOMA-IR) was calculated using the following formula: fasting glucose (mmol/L) fasting insulin (mU/L)/ 22.5, which was rearranged from the formula originally proposed by Matthews et al. 17) . The insulinogenic index, which can represent an early insulin response to oral glucose load, was defined as the ratio of the increment of plasma insulin (pmol/L) to that of blood glucose (mmol/L) 30 min after the glucose load 18) .
Coronary Angiography
Cardiac catheterization was performed according to the standard method. After intracoronary injections of isosorbide dinitrate, angiograms were obtained in 2 or more views. Analysis of the coronary angiograms was performed by an independent experienced observer without any knowledge of the results of 75-g OGTT. Patients with NGT were divided into three groups on the basis of the severity of CAD as follows: single-vessel disease (SVD) group: more than 75% stenosis of only one major coronary artery: multi-vessel disease (MVD) group: 2 or more major coronary stenoses; and 0-vessel disease (0VD): no significant stenosis of any coronary artery. Only one patient who had significant stenosis in the left main trunk was included in the MVD group. Coronary angiogram showed that subjects in the 0VD group comprised 19 patients with mild coronary artery disease without significant stenosis, 5 patients with vasospastic angina and 3 subjects with normal coronary arteries.
Criteria of Metabolic Syndrome
Patients were classified based on each criterion of metabolic syndrome using the following definition. Obesity was defined as a body mass index 25 kg/m 2 based on the Japanese criteria instead of waist circumference 19) . The other criteria were from the International Diabetes Federation (IDF) definition: triglycerides 1.7 mmol/L, high-density lipoprotein (HDL) cholesterol 1.03 mmol/L in men and 1.29 mmol/L in women, systolic blood pressure 130 mmHg or diastolic blood pressure 85 mmHg or treatment for previously diagnosed hypertension, and fasting plasma glucose concentration 5.6 mmol/L 20) .
Statistical Analysis
Data are presented as the mean SD. Statistical differences between groups were analyzed by one-way ANOVA and the chi-square test. Due to its skewed pattern of distribution, triglyceride was analyzed by Mann-Whitney's U test. Correlation between the 2 parameters was determined by simple linear regression analysis. For multivariate analysis, logistic regression analysis was used to determine the factors independently related to the presence of CAD. Statistical analysis was performed using StatView software (Version 5.0 for Windows, SAS Institute, Cary, NC). Values of p 0.05 were considered significant.
Results
Characteristics of the Study Subjects
The characteristics of the subjects in the present study are shown in Table 1 . The numbers of male patients in SVD and MVD groups were significantly higher than those in the 0VD disease group (p 0.004, both). Compared with the 0VD group, MVD and SVD groups had significantly lower levels of HDL cholesterol (p 0.001, both). The MVD group had significantly higher levels of triglyceride (p 0.04) and apoB (p 0.002) than the 0VD group. Although total cholesterol and LDL cholesterol were not significantly different among the three groups, MVD and SVD groups had significantly lower levels of LDL cholesterol/apoB ratio, which represents the presence of small, dense LDL particles, than the 0VD group (p 0.004, p 0.002, respectively). The levels of HbA1c in the MVD group were significantly higher than in the 0VD group (p 0.003). Patients in the MVD group received more -blocker therapy than those in the 0VD group (p 0.01). The total numbers of patients treated with angiotensin-converting enzyme inhibitor (ACE-) and/ or angiotensin receptor blocker (ARB) in MVD and SVD groups were significantly higher than in the 0VD group (p 0.004, p 0.003, respectively). Whereas statin was given more often in the 0VD group than in the SVD group (p 0.001), there was no significant difference between the MVD and 0VD groups. Few patients received diuretics and other lipid-lowering drugs, and there were no significant differences among the three groups. 
Insulin Responses and Severity of CAD
The Fig. 1 shows the patterns of plasma glucose and insulin during 75-g OGTT. The MVD group had significantly higher levels of 1-h glucose than the 0VD group (8.4 1.9 vs. 7.4 1.6 mmol/L, p 0.03). The levels of 2-h insulin in the MVD group and SVD group were significantly higher than those in the 0VD group (362 229 vs. 223 133 pmol/L, p 0.005, 317 216 vs. 223 133 pmol/L, p 0.05, respectively). Furthermore, the results of 75-g-OGTT showed that the MVD group had significantly higher levels of AUC of glucose and insulin than the 0VD group (14.5 1.9 vs. 13.6 1.7 mmol/L h, p 0.04, 782 432 vs. 559 256 pmol/L h, p 0.01, respectively). There were no significant differences in HOMA-IR or the insulinogenic index among the three groups ( Table 1) ; however, the levels of 2-h insulin had a significant correlation with the insulinogenic index (r 0.27, p 0.04), HOMA-IR (r 0.48, p 0.001) and AUC of insulin (r 0.76, p 0.001). The levels of 1-h glucose were positively associated with AUC of glucose (r 0.94, p 0.001) whereas there were no significant associations between AUC of glucose and 0-h, 0.5-h, 2-h glucose. Table 2 shows the association among BMI, lipid profiles and insulin parameters. Compared with other insulin parameters, the levels of 2-h insulin were more significantly correlated with lipid profiles as follows: BMI (r 0.21, p 0.02), HDL cholesterol (r 0.23, p 0.01), ln triglyceride (r 0.23, p 0.01) and LDL cholesterol/apoB (r 0.26, p 0.006). Table 3 shows the multivariate analysis for the presence of CAD defined as more than 75% stenosis in at least one major coronary artery. After adjustment for the presence or absence of each criterion of metabolic syndrome (obesity, reduced concentration of HDL cholesterol, raised concentration of triglycerides, hypertension and raised fasting plasma glucose concentration) and gender, the levels of 2-h insulin were still an independent variable for the presence of CAD.
BMI, Lipid Profiles and Insulin Parameters
Multivariate Analysis for the Presence of CAD
Discussion
The present study clearly demonstrated that an increased level of 2-h insulin after an oral glucose load is an independent risk factor of CAD in patients with NGT. A step-wise increase in insulin responses was observed from 0-vessel to multi-vessel disease, and the insulin responses in each group peaked at 1 h after glucose load. However, the levels of 2-h insulin, which represent prolonged insulin secretion, were significantly higher in the CAD groups than in the 0VD group, whereas there was no significant difference in the insulin levels at fasting, 0.5-h and 1-h after glucose load among the three groups. To our knowledge, this is the first study to indicate that a slight but significant increase in prolonged insulin secretion in subjects with NGT may play an important role in the pathogenesis of atherosclerosis.
In individuals at the pre-diabetic stage, hyperinsulinemia is considered to be a compensatory response to insulin resistance 21) . Insulin resistance is closely related with metabolic disorders and atherosclerotic 22, 23) . In addition, chronic stimulation by insulin induces the desensitization and down-regulation of insulin signaling 24) . Our results showed that the increase in the levels of 2-h insulin was significantly correlated with the total amount of insulin secretion during OGTT, as indicated by AUC of insulin, and insulin resistance, as indicated by the HOMA-IR index. We speculate that prolonged secretion of insulin after glucose load may be induced by insulin resistance, even though the levels of insulin are not very high.
We analyzed the association between 2-h insulin and the early response of pancreatic -cells to glucose load indicated by the insulinogenic index. It was reported that there was a progressive decline in the insulinogenic index from NGT to IGT and DM 25) . However, this study demonstrated that subjects with CAD maintained the function of pancreatic -cells and that the levels of the insulinogenic index were positively correlated with the levels of 2-h insulin. These findings indicate that a slight increase in prolonged insulin secretion without the exhaustion of pancreatic -cells, which may be observed at a very early stage of insulin resistance, could precede the development of coronary artery disease.
Furthermore, we found significant associations between 2-h insulin and metabolic disorders, including obesity, low levels of HDL cholesterol, high levels of triglyceride and an increase in small, dense LDL particles (ratio of LDL cholesterol to apoB). Such metabolic abnormalities are observed in patients with metabolic syndrome 26) . It is clear that metabolic syndrome based on insulin resistance is an independent coronary risk factor 27, 28) . Metabolic syndrome is also correlated with oxidized LDL, which is a major atherogenic lipoprotein 29, 30) . These findings support the notion that part of the coronary risk associated with prolonged insulin secretion could be explained by lipid abnormalities related to metabolic syndrome.
Although we found a significant association between 2-h insulin levels and lipid disorder in metabolic syndrome by univariate analysis, multivariate analysis revealed that an increase in 2-h insulin levels was an independent coronary risk factor. It was reported that hyperinsulinemia can directly lead to the development of atherosclerosis via endothelial dysfunction and proliferation of smooth muscle cells [31] [32] [33] . Elevation of blood pressure, which is induced by hyperinsulinemia 34) , may also be a contributing factor. Since this study had a cross-sectional design, we could not fully determine a significant link between prolonged insulin secretion and CAD. Furthermore, we could not fully investigate the effects of drugs on glucose and insulin metabolism. Subjects in the MVD group received more -blockers and ACE-/ARB therapy than those in the 0VD group. Several -blockers tend to have deleterious effects on insulin sensitivity and glycemic control, whereas ACE-/ARB appear to have neutral or beneficial effects on these variables 35) . Thus, treatment with these drugs may affect 2-h insu- lin levels in this population. Therefore, we need to clarify the effects of insulin secretion patterns on the development of atherosclerosis prospectively by either an observational approach or intervention with a variety of risk reduction therapies. This study had a selection bias in the 0VD group because all subjects, even in the 0VD group, had previously undergone coronary angiography for various reasons. However, we are convinced that a more significant difference in insulin secretion patterns will be observed between patients with CAD and healthy subjects with NGT. We used the number of significant stenoses to estimate the severity of CAD in this study, because similar results have been obtained by other quantitative parameters, such as the Gensini score 36) (data not shown). The presence of significant stenosis is not always correlated with acute coronary syndrome and the prognosis of each patient. We should be careful to use only the number of significant stenoses for the severity of CAD in the clinical setting. Further investigations are needed to clarify the present results.
In conclusion, our study shows that a slight but significant increase in prolonged insulin secretion, which is associated with the early stage of insulin resistance, may precede the initiation and progression of atherosclerosis in subjects with NGT. Therefore, we need to pay attention to prolonged insulin secretion as a novel coronary risk factor and evaluate insulin secretion patterns to prevent cardiovascular disease, even in subjects with NGT.
